Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionSLPIX - Small-cap Profund Investor Class
Latest Disclosed Ownership211 shares
Latest Disclosed Value $ 5,935
SLPIX - Small-cap Profund Investor Class reports 72.95% increase in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On June 22, 2026 - SLPIX - Small-cap Profund Investor Class filed a NPORT-P form disclosing ownership of 211 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $5,935 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 31, 2026 disclosing 122 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 72.95% during the quarter. The current value of the position is $6,644 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-22 2026-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 211 89 72.95 6 150.00 0.0747
2026-03-31 2026-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 122 -2 -1.61 3 0.00 0.0395
2025-12-29 2025-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 124 20 19.23 3 0.00 0.0529
2025-09-26 2025-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 104 -6 -5.45 2 0.00 0.0637
2025-06-23 2025-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 110 -13 -10.57 3 0.00 0.0877
2025-03-28 2025-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 123 18 17.14 3 0.00 0.0581
2024-12-11 2024-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 105 -5 -4.55 2 100.00 0.0449
2024-09-25 2024-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 110 10 10.00 2 0.00 0.0376
2024-06-26 2024-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 100 9 9.89 2 0.00 0.0460
2024-03-27 2024-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 91 12 15.19 1 0.0387
2023-12-28 2023-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 79 -13 -14.13 1 -100.00 0.0102
2023-09-27 2023-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 92 -1 -1.08 1 0.00 0.0381
2023-06-26 2023-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 93 20 27.40 1 0.00 0.0583
2023-04-03 2023-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 73 -15 -17.05 1 0.00 0.0355
2022-12-27 2022-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 88 14 18.92 1 0.0332
2022-09-28 2022-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 74 5 7.25 1 0.0253
2022-06-27 2022-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 69 -72 -51.06 1 0.0136
2022-03-31 2022-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 141 35 33.02 1 0.0122
2021-12-29 2021-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 106 -101 -48.79 1 -100.00 0.0096
2021-09-28 2021-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 207 86 71.07 1 0.0171
2021-06-24 2021-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 121 -4 -3.20 1 -100.00 0.0069
2021-03-29 2021-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 125 41 48.81 0 0.0043
2020-12-29 2020-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 84 -2 -2.33 0 0.0087
2020-09-24 2020-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 86 86 0 0.0112
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.